Elutia (ELUT) News Today $1.16 -0.04 (-3.33%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$1.16 0.00 (-0.09%) As of 05/22/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELUT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Elutia Targets $1.5B Breast Reconstruction Market With Antibiotic MatrixMay 19, 2026 | americanbankingnews.comElutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)May 18, 2026 | globenewswire.comElutia Inc (ELUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Revenue ShiftsMay 15, 2026 | finance.yahoo.comElutia (ELUT) Q1 2026 Earnings TranscriptMay 15, 2026 | fool.comElutia Inc. (ELUT) Q1 2026 Earnings Call TranscriptMay 14, 2026 | seekingalpha.comElutia Reports First Quarter 2026 Results and Highlights NXT-41x Progress Toward $1.5 Billion U.S. Plastic and Reconstructive Surgery MarketMay 14, 2026 | globenewswire.comElutia to Present at the 16th Annual LD Micro Invitational on May 18thMay 14, 2026 | globenewswire.comElutia Inc - Ordinary Shares - Class AMay 13, 2026 | money.usnews.comElutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026April 30, 2026 | globenewswire.comElutia Insider Trading Activity | NASDAQ:ELUT | BenzingaApril 5, 2026 | benzinga.comElutia (ELUT) price target increased by 42.86% to 5.10March 29, 2026 | msn.comElutia to Present at Sidoti’s Small-Cap Virtual Investor Conference March 18-19March 17, 2026 | markets.businessinsider.comElutia to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19March 17, 2026 | globenewswire.comElutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance WinMarch 15, 2026 | tipranks.comElutia markets another product for sale as it pivots to breast reconstruction infection preventionMarch 13, 2026 | bizjournals.comElutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)March 13, 2026 | globenewswire.comElutia Inc. (NASDAQ:ELUT) Q4 2025 Earnings Call TranscriptMarch 12, 2026 | insidermonkey.comElutia outlines launch timeline for NXT-41x in $1.5B breast reconstruction market while strengthening leadership teamMarch 11, 2026 | seekingalpha.comElutia Inc. (ELUT) Q4 2025 Earnings Call TranscriptMarch 11, 2026 | seekingalpha.comElutia (ELUT) Q4 2025 Earnings Call TranscriptMarch 11, 2026 | finance.yahoo.comElutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory ProcessMarch 11, 2026 | globenewswire.comElutia Inc (ELUT) Q4 2025: Everything You Need To Know Ahead Of EarningsMarch 10, 2026 | finance.yahoo.comElutia Adopts 2026 Inducement Equity Award PlanMarch 9, 2026 | tipranks.comElutia Regains Compliance with Nasdaq Listing RequirementsMarch 4, 2026 | globenewswire.comElutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery MarketMarch 2, 2026 | globenewswire.comElutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026February 27, 2026 | markets.businessinsider.comWhere Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™February 18, 2026 | globenewswire.comElutia (NASDAQ:ELUT) Director Guido Neels Purchases 20,000 SharesFebruary 3, 2026 | insidertrades.comInsider Buying: Elutia (NASDAQ:ELUT) Director Acquires 15,000 Shares of StockJanuary 30, 2026 | insidertrades.comElutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x MilestonesJanuary 12, 2026 | globenewswire.comElutia Inc. to Highlight NXT-41x Program at Inaugural Global BioInnovation Forum during JP Morgan Healthcare ConferenceJanuary 9, 2026 | quiverquant.comQElutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive SurgeryJanuary 9, 2026 | globenewswire.comGaithersburg biotech Elutia battles to keep Nasdaq listing after asset saleJanuary 6, 2026 | bizjournals.comElutia faces Nasdaq noncompliance, considers options to regain listingJanuary 2, 2026 | msn.comElutia (NASDAQ:ELUT) Director Kevin Rakin Purchases 50,000 SharesDecember 20, 2025 | insidertrades.comElutia (NASDAQ:ELUT) Director Buys $13,000.00 in StockDecember 19, 2025 | insidertrades.comHow The BioEnvelope Sale Is Changing Elutia’s Story and Shaping Its Future ValuationDecember 2, 2025 | finance.yahoo.comElutia management to meet with Lake StreetNovember 25, 2025 | msn.comDavid Colpman Buys 15,500 Shares of Elutia (NASDAQ:ELUT) StockNovember 20, 2025 | insidertrades.comWhy Analysts See a Shifting Story for Elutia After the BioEnvelope SaleNovember 18, 2025 | finance.yahoo.comElutia (ELUT) Price Target Decreased by 12.50% to 3.57November 17, 2025 | msn.comElutia (NASDAQ:ELUT) CEO Buys $10,125.00 in StockNovember 15, 2025 | insidertrades.comAziyo Biologics Faces Nasdaq Delisting Risk NoticeNovember 12, 2025 | tipranks.comElutia outlines plan for NXT-41x launch in $1.5B breast reconstruction market following $88M asset saleNovember 7, 2025 | msn.comElutia Inc. Advances NXT-41x Amid Financial DevelopmentsNovember 7, 2025 | msn.comElutia Inc (ELUT) Q3 2025 Earnings Call Highlights: Strategic Growth and Financial ResilienceNovember 7, 2025 | finance.yahoo.comElutia Inc. (ELUT) Q3 2025 Earnings Call TranscriptNovember 7, 2025 | seekingalpha.comElutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x DevelopmentNovember 6, 2025 | globenewswire.comWhat To Expect From Elutia Inc (ELUT) Q3 2025 EarningsNovember 5, 2025 | finance.yahoo.comHow Analyst Views Are Shifting as Elutia Refocuses After Its BioEnvelope SaleNovember 2, 2025 | finance.yahoo.com Get Elutia News Delivered to You Automatically Sign up to receive the latest news and ratings for ELUT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELUT Media Mentions By Week ELUT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELUT News Sentiment▼0.000.45▲Average Medical News Sentiment ELUT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELUT Articles This Week▼23▲ELUT Articles Average Week Get the Latest News and Ratings for ELUT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Elutia and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies NKTX News Today IMDX News Today CRBU News Today TKNO News Today ARCT News Today ARTV News Today RNAC News Today MIST News Today DTIL News Today SLGL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELUT) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elutia Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elutia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
